Monitoring Sedentary Behavior and Light Physical Activity in Patients With Stroke
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Stroke, Acute
- Sponsor
- Zealand University Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Sedentary time
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
This randomized control trial (RCT) aims to test the effect of a 12 weeks tailored behavioral intervention on stroke survivors living in the community and compare the results to a control group of stroke survivors participating in standard care. The intervention's purpose is to lower the time spend with sedentary behavior and raise the level of physical activity in stroke survivors throughout their everyday life. The intervention contains two motivational interviews with a focus on goal setting, action planning, motivation, fatigue management, and general information on life after stroke. The primary outcome for behavior change is objectively measured physical activity using an activity tracker (ActivPal4 Micro) and secondary glycohemoglobin and changes in quality of life.
Investigators
Stefan Sjørslev Bodilsen
Ph.d. student, MSPT, PT
Zealand University Hospital
Eligibility Criteria
Inclusion Criteria
- •Verified ischemic stroke or intracerebral hemorrhage
- •Modified rankin score (mRS) 1-3 at discharge
- •Discharged with at rehabilitation plan within 1-14 hospitalization days
- •Able to ambulate independently
- •Speak and understand Danish
Exclusion Criteria
- •Unable to give informed consent
- •Unable to ambulate independently
- •Mental illness
- •Other co-morbidity like terminal cancer.
Outcomes
Primary Outcomes
Sedentary time
Time Frame: 12 weeks follow-up
Time participants spend with sedentary behavior compared between the intervention and control group
Secondary Outcomes
- The General Self-efficacy Scale (GSES)(Baseline,12 and 26 weeks follow-up)
- Physical activity scale (PAS2)(Baseline,12 and 26 weeks follow-up)
- The Multi-dimensional Fatigue Inventory (MFI-20) questionnaire(Baseline,12 and 26 weeks follow-up)
- The Fugl Meyer Assessment (FMA)(Baseline,12 and 26 weeks follow-up)
- Montreal Cognitive Assessment (MoCA)(Baseline)
- Patient health questionnaire (PHQ-9)(Baseline,12 and 26 weeks follow-up)
- The Stroke Specific Quality of Life Scale (SS-QOL)(Baseline,12 and 26 weeks follow-up)
- Timed Up & Go (TUG) test(Baseline,12 and 26 weeks follow-up)
- Glycated hemoglobin (HbA1c)(Baseline,6,12 and 26 weeks follow-up)